View in EDS HTML Full Text PDF Full Text

Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out.

Saved in:
Bibliographic Details
Title: Anti-cancer compound screening identifies Aurora Kinase A inhibition as a means to favor CRISPR/Cas9 gene correction over knock-out.
Authors: Wilbie, Danny1 (AUTHOR), Eising, Selma2 (AUTHOR), Amo-Addae, Vicky2 (AUTHOR), Walther, Johanna1 (AUTHOR), Bosman, Esmeralda1 (AUTHOR), Lei, Zhiyong3 (AUTHOR), de Jong, Olivier G1 (AUTHOR), Molenaar, Jan J1,2 (AUTHOR), Mastrobattista, Enrico1 (AUTHOR) e.mastrobattista@uu.nl
Source: PLoS ONE. 9/26/2025, Vol. 20 Issue 9, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0332617